A detailed history of Siena Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Siena Capital LLC holds 342 shares of ABBV stock, worth $67,312. This represents 0.03% of its overall portfolio holdings.

Number of Shares
342
Previous 485 29.48%
Holding current value
$67,312
Previous $74,000 37.84%
% of portfolio
0.03%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$134.21 - $153.93 $19,192 - $22,011
-143 Reduced 29.48%
342 $46,000
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $64,010 - $79,418
485 New
485 $79,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Siena Capital LLC Portfolio

Follow Siena Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Siena Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Siena Capital LLC with notifications on news.